Pfizer Files 8K - Other Events
August 22 2016 - 8:42AM
Dow Jones News
Pfizer Inc. (PFE) filed a Form 8K - Other Events - with the U.S
Securities and Exchange Commission on August 22, 2016.
On August 22, 2016, Pfizer and Medivation issued a press release
announcing entry into the Merger Agreement, which is attached as
Exhibit 99.1 to this Current Report on Form 8-K and incorporated by
reference herein. Pursuant to the Merger Agreement, upon the terms
and subject to the conditions thereof, Purchaser will commence the
Offer to acquire all of the outstanding shares of common stock of
Medivation at a price of $81.50 per share, net to the seller in
cash, without interest, subject to any required withholding of
taxes. The Merger Agreement further provides that, upon the terms
and subject to the conditions thereof, following completion of the
Offer, Purchaser will be merged with and into Medivation, with
Medivation surviving the merger as a wholly owned subsidiary of
Pfizer, pursuant to the procedure provided for under Section 251(h)
of the Delaware General Corporation Law without any additional
stockholder approvals.
The Merger is subject to customary regulatory approvals and
closing conditions and is expected to close in the Third- or
Fourth- Quarter 2016. Pfizer anticipates financing the transaction
through existing cash.
The full text of this SEC filing can be retrieved at:
http://www.sec.gov/Archives/edgar/data/78003/000119312516686937/d57934d8k.htm
Any exhibits and associated documents for this SEC filing can be
retrieved at:
http://www.sec.gov/Archives/edgar/data/78003/000119312516686937/0001193125-16-686937-index.htm
Public companies must file a Form 8-K, or current report, with
the SEC generally within four days of any event that could
materially affect a company's financial position or the value of
its shares.
(END) Dow Jones Newswires
August 22, 2016 08:27 ET (12:27 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024